Фармакокинетическое взаимодействие между фторхинолонами и метилксантинами

Институт хирургии им. А.В. Вишневского РАМН, Московская медицинская академия им. И.М.Сеченова

В начало...

ЛИТЕРАТУРА

2. Холодов Л.Е., Яковлев В.В. Клиническая фармакокинетика: Рук. М.: 1985; 463.

3. Яковлев В.П., Куликова Д.А., Рудзит Э.А. Антибиотики 1976; 10: 945-954.

4. Падейская Е.Н., Яковлев В.П. Фторхинолоны. М.: 1995; 208.

5. Яковлев В.П. Антибактериальная химиотерапия в неинфекционной клинике: новые беталактамы, монобактамы и хинолоны. М 1992; 203.

6. Яковлев В.П., Яковлев С.В. Клин фармак и тер 1994; 2: 53-58.

7. Rogge M.C., Solomon W.R., Sedman A.J. et al. Clin Pharmacol Ther 1989; 46: 420-428.

8. Sorgel F., Granneman G.R., Stephan U. et al. Clin Pharmacokin 1992; 22: Suppl. 1: 75-82.

9. Beckmann J., Elsasser W., Gundert-Remy U. et al. Eur J Clin Pharmacol 1987; 33: 227-230.

10. Niki Y., Soejima R., Kawane H. et al. 28th Intersci. Conf. Antimicrob. Agents Chemother. Los Angeles, 1988; Abst. 19.

11. Sano M., Kawakatsu K., Ohkita C. et al. Eur J Clin Pharmacol 1988; 35: 161-165.

12. Кирков В., Вучидолова В., Влахов В. Съвр. Мед. 1990; XLI: 27-29.

13. Mangiarotti P., Bianchi L., Mazzola G. et al. 8th Mediterranean Congr. Chemother. Athens, 1992; Abstr. 657.

14. Robson R.A., Begg E.J. 29th Intersci. Conf. Antimicrob. Agents. Chemother. Houston, 1989; Abstr. 9.

15. Robson R.A., Begg E.J., Atkinson H.C. et al. Brit J Clin Pharmacol 1990; 29: 491-493.

16. Bachmann К.A., Schwartz J.I., Jauregui L. Ibid; 1988; 26: 191-194. 17. Schwartz J., Jauregui L., Lettier J et al. Antimicrob Agents Chemother. 1988; 32: 75-77.

18. Raoof S., Wollschlager С., Khan F.A. Amer J Med 1987; 82: Suppl. 4A: 115-118.

19. Nix D.E., DeVito J.M., Whitbread A. et al. J Antimicrob Chemother. 1987; 19: 263-269.

20. Nix D.E., Schentag J.J. J Clin Pharmacol 1988; 28: 169-178.

21. Vance-Bryan К., Guay D.R.P., Rotschafer J.C. Clin Pharmacol 1990; 19: 434-461.

22. Bowles S.К., Popovski Z., Rybak M.J. et al. Antimicrob. Agents Chemother 1988; 32: 510-512.

23. Sano M., Yamamoto I., Ueda J et al. Eur J Clin Pharmacol 1987; 32: 431-432.

24. Gregoire S.L., Grasela Т.Н., Freer J.P. et al. Antimicrob Agents Chemother 1987; 31: 375-378.

25. Cavestri R., Ciofetti M., Longhini E. et al. Eur J Clin Microbiol Infect Dis: Proc. 3th Intern. Symp. on New Quinolones. Vancouver, 1990; 45-46.

26. Okimoto N., Niki Y., Soezima R. 17th Intern. Congr. Chemother. Berlin, 1991; Abstr. 408.

27. Wijnands W.J.A., Vree T.B., Baars A.M. et al. Drugs 1987; 34: Suppl. 1: 159-169.

28. Seelmann R., Mahr G., Gottschalk B. et al. Rev Infect Dis 1989; 11: Suppl. 5: 1100.

29. Soejima R., Niki Y., Sumi M. Ibid; 1099.

30. Parent M., St.Laurent M., LeBel M. Antimicrob Agents Chemother 1990; 34: 1249-1253:

31. Nix D.E., Norman A., Schentag J.J. 29th Intersci. Conf. Antimicrob. Agents Chemother. Houston, 1989; Abstr. 7.

32. Staib A.H., Harder S. Rev. Infect Dis 1989; 11: Suppl. 5: 1092-1093.

33. Staib A.H., Harder S., Fuhr U. et al. 29th Intersci. Conf. Antimicrob. Agents Chemother. Houston, 1989; Abstr. 8.

34. Carpenter P., Granneman R. 17th Intern. Congr. Chemother. Berlin, 1991; Abstr. 410.

35. Santais M.C., Grossriether H., Callens E. et al. Ibid; Abstr. 407.

36. Johnson R.D., Wilson J,, Dorr M.B. et al. Clin Pharmacol 1995; 33: 936.

37. Mahr S., Seelmann В., Gottschalk В. et al. 30th Intersci Conf. Antimicrob. Agents Chemother. Atlanta, 1990; Abstr. 1259.

38. Okimoto N., Sumi M., Nakahama C. et al. Eur J Clin Microbiol Infect Dis 1991; Spec. iss: 525-586.

39. Hasegawa Т., Miyatake H., Yamaki K. at al. Ibid; 586-587.

40. Takagi К., Yamaki К., Nadai M. et al. Antimicrob Agents Chemother 1991; 35: 1137-1141.

41. Fuhr U., Kinzig M., Cesana M. et al. 18th Intern. Congr. Chemother., Stockholm, 1993; Abstr. 393.

42. Sorgel F, Kinzig M. Amer J Med 1993; 94: Suppl. 3А: 56-69.

43. Niki Y., Hashiguchi К., Okimoto N. Chest 1992: 101: 881.

44. Nix D.E. In: Quinolone Antimicrobial Agents. Hooper D.C., Wolfson J.S. eds. 1993: 245-257.

45. Peloquin C.A., Nix D.E., Sedman A.J. et al. Rev Inf Dis 1989; 11: Suppl. 5: 1095.

46. Staib A.H., Stille W., Dietlein G. et al. Drugs 1987; 34: Suppl. 1: 170-174.

47. Sttille W., Harder S., Mieke S. et al. J Antimicrob Chemother 1987; 20: 729-734.

48. Harder S., Fuhr U., Staib A.H. Amer J Med 1989; 87: Suppl. 5A: 89-91.

49. Harder S., Staib A.H., Bear C. et al. Eur J Clin Pharmacol 1988; 35: 651-656.

50. Healy D.P., Polk R.E., Kanawati L. et al. Antimicrob Agents Chemother 1989; 33: 474-478.

51. Ludwig F., Szekely E., Csiba A. In: Ciproflaxacine in Clinical Practice: New Light on Established and Emerging Uses. Stutgart, 1990; 219-222.

52. Mahr G., Sorgel F., Granneman G.R. et al. Clin Pharmac 1992; 22: Suppl. 1: 90-97.

53. Mahr G., Sorgel F., Noje M. et al. l7th Irtern. Congr. Chemother. Berlin, 1991; Abstr. 417.

54. Polk R.E. Amer J Med 1989; 87: Suppl. 5A: 76-81.

55. Healy D.P., Polk R.S., Schoenle J et al. 30th lntersci. Conf. Antimicrob. Agents Chemother. Atlanta, 1990; Abstr. 1008.

56. Patel I.H., Holazo A.A., Apostol L. et al. 3rd Intern. Symp. on new Quinolones. Vancouver, 1990; Abstr. 423.

57. Fuhr U., Wolff Т., Harder S. et al. Eur J Clin Pharmacol 1989; 36: Suppl.: 272.

58. Okazaki O., Kurata Т., Tachizawa H. Chemotherapy. Basel 1988; 34: 149-154.

59. Okazaki O., Miyazaki К., Tachizawa H. Ibid; 1987; 33: 402-411.

60. Kunze К,, Wienkers L., Trager W. 17th Intern. Corg. Chemother. Berlin, 1991; Abastr. 433.

61. Sorgel F., Koch U., Metz R. et al. Proc. 26th Intersci. Conf. Antimicrob. Agents Chemother. New Orleans, 1986; 390.

62. Portmann R. Drugs 1993; 45: Suppl. 3: 471.

63. Weidekamm E., Portman R., McClelland G. et al. 8th Mediterranean Congr. Chemother. Athens, 1992; Abstr. 495.

64. Sorgel F., Mahr G., Granneman G.R. et al. Clin Pharmac 1992; 22: Suppl. 1: 65-74.

65. Gries J.M., Honorato J., Taburet A.M. et al. Intern J Clin Pharmacol Ther 1995; 33: 585-587.

66. Wingender W., Beermann D., Forster D. et al. 1st Intern. Ciprofloxacin Workshop. Leverkusen, 1985; Proc Excerpts Med 1986; 136-140.

67. Shiba K., Yoshida M., Kachi M. et al. 17th Intern. Congr. Chemother. Berlin, 1991; Abstr. 415.

68. Barriere S.L., Kaatz G.W., Seo S.M. Antimicrob Agents Chemother 1989; 33: 589-590.

69. Chandler M.H.H., Toler S.M., Rapp R.P. et al. Ibid; 1990: 34: 442-447.

70. Edwards D.J., Bowles S.K., Svensson C.K. et al. Clin Pharmac 1988; 15: 194-204.

71. Logamann С., Ohnhaus E.E. 26th Intersci. Conf. Antimicrob. Agents Chemother. New Orleans, 1986; Abstr. 481.

72. Ludwig E., Szekely E., Csiba A. et al. J Antimicrob Chamother 1988; 22: 61-67.

73. Graber H., Ludwig E., Magyar Т. et al. Rev. Infect Dis 1989; 11: Suppl. 5: 1093-1094.

74. Wijnands W.J.A., Vree Т.В., Herwaarden C.L.A. Brit J Clin Pharmacol 1986; 22: 677-683.

75. Sarkar M., Polk R.E., Guzelian P.S. et al. Antimicrob Agents Chemother 1990; 34: 594-599.

76. Paton J.H., Reeves D.S. Drug Safety 1991; 6: 8-27.

77. Rubinstein E., Segev S. Ciprofloxacin; clin. monogr. Manchester, 1988; 44-46.

78. Koup J.R., Toothaker R.D., Posvar.E. et al. Antimicrob Agents Chemother 1990; 34: 803-807.